The Patterning Problem: Why Making New Cells Is Not Enough
New cells cannot automatically recreate a functioning organ. This essay argues that regenerative engineering must demonstrate appropriate cell composition, spatial geometry, physiological connectivity and performance. Examples from tissue patches and neural repair illustrate why proliferation alone can be ineffective or harmful, and why safety and architecture should be central endpoints.
Proliferation is not reconstruction
A damaged organ may require replacement cells, but a growing collection of cells is not yet a functioning organ. Regeneration demands correct cell identity, tissue boundaries, microvascular networks, innervation, extracellular support and mechanical integration. Tumors demonstrate that proliferation can be vigorous and biologically disastrous. Scar tissue demonstrates that survival and wound closure can occur without restoring the original architecture. This creates a central problem for regenerative engineering: how can new growth be constrained into useful form?
Lessons from development and transplantation
Embryonic tissues develop through reciprocal signaling. A developing blood vessel influences adjacent tissue, while organ-specific matrix, mechanical strain and morphogen gradients influence maturation. Transplanted stem cells face an older or diseased niche with immune defenses, altered vascular supply and sometimes fibrosis. Even if injected cells express attractive laboratory markers, they may fail to engraft, differentiate incorrectly or provide a temporary paracrine effect rather than lasting replacement. A genuine regenerative claim must distinguish these possibilities.
A reconstruction standard
We propose measuring regeneration along four axes: composition, geometry, connection and function. Composition asks whether appropriate cell types exist. Geometry asks whether they occupy the right places. Connection evaluates innervation, perfusion and signaling integration. Function asks whether the restored tissue performs useful work under real demand. An organoid can be impressive on composition while immature on connection; a nerve graft can restore some continuity but not adequate function.
What may limit ambition
Some organs lack readily accessible progenitors or have architecture that is difficult to recreate after extensive injury. Stimulating developmentally powerful pathways can increase the risk of dysplasia and cancer. The best near-term clinical success may be partial functional restoration, not complete anatomical replacement. That is still meaningful progress, provided it is described accurately rather than marketed as a universal awakening of dormant regeneration.
A clinical thought experiment
An engineered cardiac patch may contain beating cardiomyocytes but fail clinically if it cannot perfuse, conduct electrical signals safely or integrate mechanically. A laboratory success in cell identity can therefore coexist with an organ-level failure. Conversely, a patch that offers passive structural support may improve function without producing extensive new muscle. Either result can be useful when described accurately.
What would discriminate among explanations
The proposed four-axis reconstruction standard should be challenged against actual patient outcomes. If geometry, cell type and connectivity add no predictive value beyond functional testing, the framework is unnecessarily elaborate. If they explain why plausible therapies fail, it can guide more discriminating experimental design without promising complete organ replacement.
Selected scientific readings
- Molecular basis of positional memory in limb regeneration. Nature (2025). https://www.nature.com/articles/s41586-025-09036-5
- Lu Y et al. (2020). Reprogramming to recover youthful epigenetic information and restore vision. Nature. https://www.nature.com/articles/s41586-020-2975-4
- Neural control of growth and size in the axolotl limb regenerate. eLife (2021). https://elifesciences.org/articles/68584